Commonwealth Equity Services LLC Sells 2,023 Shares of Sanofi (NASDAQ:SNY)

Commonwealth Equity Services LLC lowered its stake in shares of Sanofi (NASDAQ:SNY) by 1.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 161,454 shares of the company’s stock after selling 2,023 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Sanofi were worth $7,787,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the stock. Synergy Asset Management LLC purchased a new position in Sanofi during the 4th quarter valued at $25,000. McClarren Financial Advisors Inc. boosted its holdings in Sanofi by 952.6% during the 4th quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company’s stock valued at $28,000 after acquiring an additional 543 shares during the period. Sunbelt Securities Inc. boosted its holdings in Sanofi by 72.1% during the 3rd quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock valued at $43,000 after acquiring an additional 313 shares during the period. Sierra Ocean LLC purchased a new position in Sanofi during the 4th quarter valued at $44,000. Finally, Versant Capital Management Inc purchased a new position in Sanofi during the 4th quarter valued at $54,000. Institutional investors own 14.04% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on SNY shares. Deutsche Bank Aktiengesellschaft upgraded Sanofi from a “sell” rating to a “hold” rating in a report on Thursday, January 30th. Sanford C. Bernstein upgraded Sanofi to a “strong-buy” rating in a report on Thursday, January 30th. Finally, StockNews.com cut Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Two research analysts have rated the stock with a hold rating, one has issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $60.00.

Sanofi Price Performance

Shares of SNY stock opened at $57.79 on Friday. The company has a current ratio of 1.46, a quick ratio of 1.14 and a debt-to-equity ratio of 0.15. The stock has a market capitalization of $146.66 billion, a price-to-earnings ratio of 23.21, a P/E/G ratio of 1.01 and a beta of 0.58. Sanofi has a twelve month low of $45.22 and a twelve month high of $60.12. The stock has a fifty day simple moving average of $54.39 and a two-hundred day simple moving average of $52.92.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings data on Thursday, January 30th. The company reported $0.70 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.70. Sanofi had a return on equity of 25.61% and a net margin of 12.77%. On average, analysts predict that Sanofi will post 4.36 EPS for the current fiscal year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.